Even though fully- funded scholarships at the undergraduate level in the US are a rare achievement for Bangladeshi students, Nafis Ul Haque Sifat and Sanjida Nusrat Ananna have successfully pulled it off
The Cornell Undergraduate Research Board student-run Spring Symposium, held May 4, provided a space for undergraduates to present scholarly research in front of an audience.
Five million tons of apple pomace, the waste product created in juice production, goes into U.S. landfills every year. But new student research shows how this trash just might become treasure – when transformed into biofuel.“If we already have all th
Written by Lori Uildriks on May 5, 2021 Fact checked by Hannah Flynn, MS
A survey of adults in the United States reveals that many are confused about the protection offered by the second dose of the COVID-19 vaccines. Gabby Jones/Bloomberg via Getty Images
A recently published survey shows that a significant proportion of people in the United States are not informed of the optimal timing of vaccination for protection and recommended preventative measures post-COVID-19 vaccination.
Of the respondents, 20% mistakenly believed that COVID-19 vaccines offer strong protection before the second dose, and 36% were unsure, possibly resulting in skipped second doses.
Results of the study indicate the need for educational campaigns, to build trust and provide scientifically sound information about vaccine benefits.
April 28, 2021
Though more than 142 million Americans have received at least one dose of COVID-19 vaccine to date, public confusion and uncertainty about the importance of second doses and continued public health precautions threaten to delay a U.S. return to normalcy, according to Cornell-led research published April 28 in the New England Journal of Medicine.
In a nationally representative survey of more than 1,000 American adults conducted in February, less than half of respondents said they believed the Moderna and Pfizer-BioNTech vaccines provided strong protection against COVID-19 a week or two after a second dose, consistent with guidance from the U.S. Centers for Diseases Control and Prevention (CDC), the researchers found. One-fifth believed the vaccines provided strong protection after only one dose, and another 36% were unsure.